Ameritas Investment Partners, Inc. Exelixis, Inc. Transaction History

Ameritas Investment Partners, Inc.

$2.84 Billion
Q2 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 61,958 shares of EXEL stock, worth $1.61 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

61,958

Previous 66,859 7.33%

Holding current value

$1.61 Million

Previous $1.59 Million 12.23%

% of portfolio

0.05%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$20.34 - $23.73 $99,686 - $116,300	-4,901 Reduced 7.33%	61,958 $1.39 Million
Q1 2024 May 13, 2024	SELL	$20.17 - $23.93 $36,386 - $43,169	-1,804 Reduced 2.63%	66,859 $1.59 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $52,783 - $66,164	-2,742 Reduced 3.84%	68,663 $1.65 Million
Q3 2023 Nov 13, 2023	SELL	$19.04 - $22.74 $188,781 - $225,467	-9,915 Reduced 12.19%	71,405 $1.56 Million
Q2 2023 Aug 11, 2023	SELL	$18.17 - $20.48 $26,291 - $29,634	-1,447 Reduced 1.75%	81,320 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $43,433 - $61,687	-2,770 Reduced 3.24%	82,767 $1.3 Million
Q2 2022 Aug 12, 2022	BUY	$17.44 - $23.16 $16,376 - $21,747	939 Added 1.11%	85,537 $1.78 Million
Q4 2021 Feb 11, 2022	BUY	$15.84 - $21.88 $18,120 - $25,030	1,144 Added 1.37%	84,598 $1.55 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $20,391 - $26,446	-1,251 Reduced 1.48%	83,454 $1.76 Million
Q2 2021 Aug 06, 2021	SELL	$17.95 - $25.56 $18,650 - $26,556	-1,039 Reduced 1.21%	84,705 $1.54 Million
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $31,888 - $43,003	-1,734 Reduced 1.98%	85,744 $1.72 Million
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $25,548 - $33,297	-1,236 Reduced 1.39%	87,478 $2.14 Million
Q2 2020 Aug 05, 2020	BUY	$16.46 - $27.42 $50,976 - $84,919	3,097 Added 3.62%	88,714 $2.11 Million
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $43,298 - $55,469	-2,449 Reduced 2.78%	85,617 $1.51 Million
Q3 2018 Nov 13, 2018	BUY	$15.87 - $22.4 $96,267 - $135,878	6,066 Added 7.4%	88,066 $1.56 Million
Q2 2018 Aug 13, 2018	BUY	$18.56 - $22.45 $1.52 Million - $1.84 Million	82,000 New	82,000 $1.77 Million

Others Institutions Holding EXEL

# of Institutions

460

Shares Held

240M

Call Options Held

2.04M

Put Options Held

1.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.35B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Exelixis, Inc. Transaction History